Early life serological profiles and the development of natural protective humoral immunity to Streptococcus pyogenes in a high burden setting
Keeley, A. J.; Camara, F.; Armitage, E.; de Crombrugghe, G.; Sillah, J.; Fofana, M. L.; Rollinson, V.; Senghore, E.; Jammeh, M.; Whitcombe, A.; Bittaye, A.; Cesesay, H.; Cesesay, I.; Manneh, M.; Samateh, B.; Carducci, M.; Rovetini, L.; Boero, E.; Massai, L.; Sanyang, C.; Camara, O.; Cessay, E.; iturriza, M.; Moriel-gomes, D.; Kucharski, A.; smeesters, P.; Botteaux, A.; Jagne, Y.-J.; Moreland, N.; Clarke, E.; Kampmann, B.; Marks, M.; Rossi, O.; Salje, H.; Turner, C.; de Silva, T.
Show abstract
Streptococcus pyogenes leads to 500,000 deaths annually; many due to rheumatic heart disease in low-income settings. Limited understanding of natural protective immunity to S. pyogenes hinders vaccine development. We describe the evolution of serological profiles to conserved vaccine-antigens and type-specific M peptides from birth and throughout the life course in The Gambia. As placentally-transferred IgG waned after birth, serological evidence of new exposure was seen in 23% infants during the first year of life. Following culture-confirmed S. pyogenes events, the highest IgG increases occurred in children under two years following both pharyngeal and skin disease, and asymptomatic carriage at both sites. Higher IgG to conserved antigens SLO, SpyCEP and SpyAD correlated with functional activity and were associated with protection from culture-confirmed events following adjustment for age and anti-M protein IgG levels. Our data provide the first evidence of protection associated with humoral immunity to conserved vaccine candidate antigens in humans.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Elevated mucosal antibody responses against SARS-CoV-2 are correlated with lower viral load and faster decrease in systemic COVID-19 symptoms 95%
- Seven-month kinetics of SARS-CoV-2 antibodies and protective role of pre-existing antibodies to seasonal human coronaviruses on COVID-19 95%
- Typically asymptomatic but with robust antibody formation: Children’s unique humoral immune response to SARS-CoV-2 95%
Similar papers in this journal
Similar papers in this journal
- Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infection 94%
- Streptococcus pneumoniae colonisation associates with impaired adaptive immune responses against SARS-CoV-2 93%
- Contribution of endogenous and exogenous antibodies to clearance of SARS-CoV-2 during convalescent plasma therapy 93%
Similar papers in this journal
- COVID-19 convalescents exhibit deficient humoral and T cell responses to variant of concern Spike antigens at 12 month post-infection 94%
- A SARS-CoV-2 variant of concern triggers Fc effector function with increased cross-reactivity 94%
- Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells 94%
Similar papers in this journal
- Characterising heterogeneity and sero-reversion in antibody responses to mild SARS⍰CoV-2 infection: a cohort study using time series analysis and mechanistic modelling 94%
- Anti-SARS-CoV-2 Antibodies Persist for up to 13 Months and Reduce Risk of Reinfection 94%
- The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylatedIgG1 in naive but not antigen-experienced vaccinees 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.